Koers RxElite, Inc. Other OTC
Aandelen
RXEI
US78347X1054
Farmaceutische producten
Omzet 2006 | 14,17 mln. 13,25 mln. | Omzet 2007 | 2,81 mln. 2,63 mln. | Marktkapitalisatie | 84,94 mln. 79,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | 7 mln. 6,55 mln. | Nettowinst (verlies) 2007 | -17 mln. -15,9 mln. | EV/omzet 2006 * | - |
Nettoliquiditeiten 2006 | 789K 738K | Nettoliquiditeiten 2007 | 8,6 mln. 8,04 mln. | EV/omzet 2007 | 27,1 x |
K/w-verhouding 2006 * |
-
| K/w-verhouding 2007 |
-3,2
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 68,17% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Earl E. Sullivan
CEO | Chief Executive Officer | 52 | 13-07-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,28% | 43,67 mld. | |
+26,21% | 22,79 mld. | |
+19,25% | 15,45 mld. | |
+18,36% | 14,29 mld. | |
+53,42% | 12,83 mld. | |
-0,05% | 6,79 mld. | |
-11,88% | 6,52 mld. | |
+12,62% | 5,59 mld. | |
-8,87% | 5,73 mld. |